Beyond the Concept – Concept Systems
For an episode of “Beyond the Concept” podcast, a show by Concept Systems, host Tyler Kern chatted with John Miller, the principal engineer at Rockwell Automations, and Jerry Flynn, the company’s principal controls engineer. The trio particularly discussed Programmable Numerical Control, mostly known by its initials, PNC, and how Rockwell has been a premier leader…
Latest
Architecture & Design
System Integration Field and CSIA’s Role
Jose Rivera, CEO of Control System Integrators Association (CSIA), joined host Daniel Litwin to explain CSIA’s role in the systems integration field in the latest Beyond the Concept podcast episode. In 2015, Rivera, an electrical engineer, transitioned from serving large automation equipment suppliers to becoming the CEO of CSIA, a 500-member organization. Rivera explained that…
Beyond the Concept - Concept Systems
Beyond the Concept: Managing the Risk of Using Out-of-Date Parts and Products in a Facility
Facilities can ill afford to have equipment go down with today’s supply chain challenges. Lost hours could quickly become lost days if a replacement is unavailable. Sam Cafferata, Principal Engineer at Concept Systems, spoke with Tyler Kern about this all-too-real issue and what facilities can do to ensure their equipment is up-to-date and in good…
Beyond the Concept - Concept Systems
Steve Strong’s Vision for Concept Systems Going into 2023
After a momentous twenty-three years, Michael Helm has stepped down in his role as CEO with Concept Systems. Helm passed the torch down to Steve Strong, who chatted with host Tyler Kern about his future-forward visions for Concept Systems. After spending almost 15 years at the Boeing Company, Strong knows a thing or two about…
Architecture & Design
Navigating Greenfield Projects with Rick Pruden and Ron Schiedler
Two of the main contributing factors driving the financial success of greenfield projects are budgeting and schedule. On the latest episode of the Beyond the Concept podcast, Rick Pruden, Strategic Solutions Specialist at Concept Systems, and Ron Schiedler, Principal Engineer at Concept Systems, spoke to Beyond the Concept’s Tyler Kern about mitigating these risk factors…
Beyond the Concept - Concept Systems
Making Complex Robotic Applications Simple with Justin Garski and Evan Gonnerman
We breathe without thinking. Blink without noticing. But when it comes down to it, all of our normal bodily functions are not as easy and effortless as they appear—at least not for complex robotic applications. Justin Garski, the Americas OEM Segment Manager for Packaging, Converting, Print and Web at Rockwell and Evan Gonnerman, Senior Controls…
Beyond the Concept - Concept Systems
Beyond the Concept: Automation in the Airlines and Aerospace Markets
Steve Strong, Regional Engineering Manager, Seattle, at Concept Systems, spoke with Tyler Kern about some of the automation challenges in the airline and aerospace industries. Something both markets have in common: they each have expensive and complex products to manufacture and automate. Strong said because of these complexities, the proposals Concept Systems does and…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
